Pharmaceutical Business review

Alkermes receives inhaled program termination notice from Eli Lilly

The termination will become effective in 90 days. The termination of the agreement also results in the termination of the Air Insulin supply agreement. Alkermes is evaluating the impact of the termination of the Air Insulin program on its business and will provide further details following a comprehensive business analysis.